 |
|
|
|
|
 |
|
INAUGURAL ISSUE: BIO OUTSOURCING ASIA Volume 1 Issue 2 April 2008
In this issue: Opportunities and Challenges in India, Outsourcing to India, Spotlight on Hyderabad
Emerging Market Opportunities
India making big strides in the Vaccine market, By Dr. Anjali Shukla, Accure Labs Pvt. Ltd.
Spotlight on Hyderabad
Hyderabad: A Top Destination for Life Sciences, By CanBiotech
ICICI Knowledge Park: Nurturing an Environment for Innovation, By Deepanwita Chattopadhyay, CEO ICICI Knowledge Park
Partnering Opportunities and Models
Contract Research Organizations in India: Models and Partnerships, By CanBiotech
Partnering in Hyderabad, India-Opportunities in the Diagnostics and Biomedical Industries, By Dr. Konrad Faulstich, Head of Business Development ESE GmbH and Dr. Rathnagiri Polavarapu, CEO Genomix Molecular Diagnostics
Technology Transfer
Taiwan’s Technology Transfer Promotion Platform, By Dave Silver, President Biotech East Co. Ltd.
Advice from our Outsourcing Service Providers
India Pharma: Informatics and Analytics Outsourcing, By Chandra Shekhar Prasad, marketRx
India Bioinformatics-Challenges to Overcome, By Poonam Bhana, ValueNotes Outsourcing Practice
|
| |
|
|
|
|
|
|
|
|
Format and
Editorial Calendar
Formats: Online, Digital, and Print
Subscription: 25,000
Content: Feature Stories, Trends and Analysis, Case Studies,
Technology Profiles, Company Profiles, News, Events
Access: Free
November-December 2007:
Outsourcing Opportunities in Asia, The BioIndia, The BioTaiwan, The
BioChina, and The BioMalaysia Perspectives
March-April 2008: India-Emerging
Business Models, India vs. China-Competitors?, A Profile of India's
Leading Companies and Service Providers
July-August 2008: China Industry
Overview, CRO's in China, Spotlight on Taiwan, A Profile of CRO's
in China
November-December 2008:
Opportunities in and Challenges Facing
Malaysia, Malaysia's Leading Companies and Service Providers, A
Profile of MNC's in Malaysia
Contact the Editor at editor@canbiotech.com
to learn more about writing for and featuring your
expertise and/or company in our publication.
Advertisement
Opportunities:
Download the Bio Outsourcing Asia Advertising and
Media Kit
Event postings: Online, Monthly
Bio Outsourcing Asia Newsletter, and Publication
Product Advertisements: Online and Publication
Service Advertisements: Online, Monthly Bio Outsourcing Asia Newsletter, and
Publication
Technology Postings: Online,
Monthly Bio Outsourcing Asia Newsletter, and
Publication
Advertorial: Online and Publication
Contact M. Damani damani@canbiotech.com to learn
more about advertising opportunities in our upcoming issues.
|
| |
|
|
|
|
Upcoming Issue: April 2008
Focus: Opportunities and Challenges in India
- Spotlight on Hyderabad
- CROs in India
- India's Vaccine Market
- Emerging Business Models in India
- Technological Opportunities in India
Contact the Editor to write for this issue or to include your company press releases
editor@canbiotech.com
April Issue Advertisers to Date:
Contact us at ads@canbiotech.com to advertise in this issue. SPACE IS LIMITED.
Inaugural Issue Advertisers: December 2007
|
| |
|
|
|
|
|
INDIA is rapidly becoming a vital, mature partner within
international bio/pharmaceutical markets. The new peer-reviewed,
joint Society for Industrial Microbiology publication,
Advances in Biopharmaceutical Technology in India,
indicates that Indian companies and suppliers plan to achieve a 10%
global biopharmaceutical market share within the foreseeable
future.
This study provides an in-depth view of the biopharmaceutical
industry in India. It describes the current state of technology,
partnership opportunities, science aspects, and general business
practices. Readers will find accurate, peer-reviewed analysis of
business opportunities to help them create effective India
Strategies.
By the Numbers:
- 35 Internationally Recognized Authors
- 766 Pages
- 20 Chapters
- 14 Peer reviewers
- 1,178 References
- 118 Tables and 49 Figures
What You'll Get:
- Expert, unbiased, analysis: 35 internationally
recognized authors, sponsored by Society for Industrial
Microbiology
- Peer-reviewed: Editorial board and review ensures
relevance, accuracy, and substance.
- Unparalleled access to experts: Purchasers have unique
access to study contributors and authors.
- Fresh, relevant information: Subject matter experts
combine their in-depth knowledge with current, primary
data.
India is investing heavily in technologies and education, and will
be one of the world's largest markets for vaccines and
biopharmaceuticals.
Get ready for the India opportunity
This comprehensive study of the science and business of
biopharmaceuticals in India: Advances in
Biopharmaceutical Technology in India provides answers,
from world- recognized subject matter experts in India, the US, and
Europe.
Advances in Biopharmaceutical Technology in INDIA describes the
Indian industry, organizations, and government plans and goals. It
details successes, problems, and gaps. The study covers issues
critical to biomanufacturers, CMOs, CROs, and suppliers, and
describes the current state of technology, partnership
opportunities, and general business practices.
A ready reference for all aspects of biopharmaceuticals in
India
India has one of the world's fastest growing economies, and the
second-largest population, with 1.1 billion people. Its middle
class is the engine providing the economic power to support an
expanding domestic healthcare industry. Learn how to take advantage
of the opportunities that exist for organizations that establish
solid business and scientific strategies.
For complimentary
chapter abstracts Click Here
Link to more
information and pricing
For Email
information, Click Here (email)
|
| |
|
|
|
|
